Event
FDA approves oral semaglutide (Wegovy)
Global · Regulatory
What to watch
Why variis flagged this
Oral semaglutide cleared by the FDA; commercial launch followed in January 2026.
Common questions
- FDA approves oral semaglutide (Wegovy): what happened?
- Oral semaglutide cleared by the FDA; commercial launch followed in January 2026.
- FDA approves oral semaglutide (Wegovy): when?
- 6 December 2025. variis records dates only to the precision the source published, so a date given here as a month or a year is not being rounded from something more exact.
- FDA approves oral semaglutide (Wegovy): who is involved?
- Novo Nordisk
- FDA approves oral semaglutide (Wegovy): why does variis track it?
- It is recorded as regulatory, one of the categories variis follows across the longevity market.
Keep reading
Related coverage from the newsroom.
Every entity profile on variis is sourced. Not medical or investment advice.